乐普（北京）医疗器械股份有限公司

Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. It is specialized in developing, manufacturing and marketing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, in vitro diagnostic equipment and biomarkers, DSA systems and surgical staplers. In 2009, Lepu Medical successfully went public, and listed on ChiNext Shenzhen Stock Exchange Market (stock code: 300003). Lepu Medical was established in 1999, and made the first drug-eluting stent in China. In 2009, Lepu is listed on Chinese, Shenzhen, stock market. Market value is about 8.5 billion USD unitl Dec 2020. Lepu take leading market share in China for coronary stents (25%) and occlusion devices (35%). About the business, we take Leading position in China, specialized in developing, manufacturing and marketing of high-tech cardiology products. Lepu Currently has 32 primary subsidiaries globally, as Carewell technology in US, Lepu India, Lepu Africa. Lepu is China National Interventional Cardiology Medical Instruments & Engineering Technology Research Center Named by China science and technology commission (government). Lepu is the only medical company in China that own this title.